232 related articles for article (PubMed ID: 24890344)
21. Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism in obese, nondiabetic humans.
Padilla N; Maraninchi M; Béliard S; Berthet B; Nogueira JP; Wolff E; Nicolay A; Bégu A; Dubois N; Grangeot R; Mattei C; Vialettes B; Xiao C; Lewis GF; Valéro R
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2330-7. PubMed ID: 25104797
[TBL] [Abstract][Full Text] [Related]
22. Role of triglyceride-rich lipoproteins from the liver and intestine in the etiology of postprandial peaks in plasma triglyceride concentration.
Cohn JS; McNamara JR; Krasinski SD; Russell RM; Schaefer EJ
Metabolism; 1989 May; 38(5):484-90. PubMed ID: 2725288
[TBL] [Abstract][Full Text] [Related]
23. Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides.
Castro Cabezas M; Erkelens DW; Kock LA; De Bruin TW
Eur J Clin Invest; 1994 Oct; 24(10):669-78. PubMed ID: 7851467
[TBL] [Abstract][Full Text] [Related]
24. Acute resistance exercise attenuates fasting and postprandial triglyceridemia in women by reducing triglyceride concentrations in triglyceride-rich lipoproteins.
Zotou E; Magkos F; Koutsari C; Fragopoulou E; Nomikos T; Sidossis LS; Antonopoulou S
Eur J Appl Physiol; 2010 Nov; 110(4):869-74. PubMed ID: 20607278
[TBL] [Abstract][Full Text] [Related]
25. Temporal pattern of de novo lipogenesis in the postprandial state in healthy men.
Timlin MT; Parks EJ
Am J Clin Nutr; 2005 Jan; 81(1):35-42. PubMed ID: 15640457
[TBL] [Abstract][Full Text] [Related]
26. Postprandial hyperlipidemia: another correlate of the "hypertriglyceridemic waist" phenotype in men.
Blackburn P; Lamarche B; Couillard C; Pascot A; Bergeron N; Prud'homme D; Tremblay A; Bergeron J; Lemieux I; Després JP
Atherosclerosis; 2003 Dec; 171(2):327-36. PubMed ID: 14644404
[TBL] [Abstract][Full Text] [Related]
27. High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet.
Silbernagel G; Kovarova M; Cegan A; Machann J; Schick F; Lehmann R; Häring HU; Stefan N; Schleicher E; Fritsche A; Peter A
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2288-92. PubMed ID: 23015656
[TBL] [Abstract][Full Text] [Related]
28. Reduction in liver fat by dietary MUFA in type 2 diabetes is helped by enhanced hepatic fat oxidation.
Bozzetto L; Costabile G; Luongo D; Naviglio D; Cicala V; Piantadosi C; Patti L; Cipriano P; Annuzzi G; Rivellese AA
Diabetologia; 2016 Dec; 59(12):2697-2701. PubMed ID: 27650287
[TBL] [Abstract][Full Text] [Related]
29. Novel role of enteral monosaccharides in intestinal lipoprotein production in healthy humans.
Xiao C; Dash S; Morgantini C; Lewis GF
Arterioscler Thromb Vasc Biol; 2013 May; 33(5):1056-62. PubMed ID: 23471231
[TBL] [Abstract][Full Text] [Related]
30. Postprandial hemorrheology and apolipoprotein B metabolism in patients with familial hypertriglyceridemia.
Otto C; Pschierer V; Soennichsen AC; Schwandt P; Richter WO
Metabolism; 1997 Nov; 46(11):1299-304. PubMed ID: 9361689
[TBL] [Abstract][Full Text] [Related]
31. Minor components of olive oil facilitate the triglyceride clearance from postprandial lipoproteins in a polarity-dependent manner in healthy men.
Cabello-Moruno R; Martinez-Force E; Montero E; Perona JS
Nutr Res; 2014 Jan; 34(1):40-7. PubMed ID: 24418245
[TBL] [Abstract][Full Text] [Related]
32. Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.
Schwartz EA; Koska J; Mullin MP; Syoufi I; Schwenke DC; Reaven PD
Atherosclerosis; 2010 Sep; 212(1):217-22. PubMed ID: 20557887
[TBL] [Abstract][Full Text] [Related]
33. Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding.
Chong MF; Hodson L; Bickerton AS; Roberts R; Neville M; Karpe F; Frayn KN; Fielding BA
Am J Clin Nutr; 2008 Apr; 87(4):817-23. PubMed ID: 18400702
[TBL] [Abstract][Full Text] [Related]
34. Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study.
Matikainen N; Söderlund S; Björnson E; Pietiläinen K; Hakkarainen A; Lundbom N; Taskinen MR; Borén J
Diabetes Obes Metab; 2019 Jan; 21(1):84-94. PubMed ID: 30073766
[TBL] [Abstract][Full Text] [Related]
35. Separation of postprandial lipoproteins: improved purification of chylomicrons using an ApoB100 immunoaffinity method.
Jones GM; Caccavello R; Palii SP; Pullinger CR; Kane JP; Mulligan K; Gugliucci A; Schwarz JM
J Lipid Res; 2020 Mar; 61(3):455-463. PubMed ID: 31888979
[TBL] [Abstract][Full Text] [Related]
36. Metabolic heterogeneity underlying postprandial lipemia among men with low fasting high density lipoprotein cholesterol concentrations.
Couillard C; Bergeron N; Bergeron J; Pascot A; Mauriège P; Tremblay A; Prud'homme D; Bouchard C; Després JP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4575-82. PubMed ID: 11134111
[TBL] [Abstract][Full Text] [Related]
37. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
Green CJ; Pramfalk C; Charlton CA; Gunn PJ; Cornfield T; Pavlides M; Karpe F; Hodson L
BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32188593
[TBL] [Abstract][Full Text] [Related]
38. HDL-associated apoCIII plays an independent role in predicting postprandial hypertriglyceridemia.
Zhang T; Tang X; Mao L; Chen J; Kuang J; Guo X; Xu D; Peng D; Yu B
Clin Biochem; 2020 May; 79():14-22. PubMed ID: 32045574
[TBL] [Abstract][Full Text] [Related]
39. Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity.
Taskinen MR; Söderlund S; Bogl LH; Hakkarainen A; Matikainen N; Pietiläinen KH; Räsänen S; Lundbom N; Björnson E; Eliasson B; Mancina RM; Romeo S; Alméras N; Pepa GD; Vetrani C; Prinster A; Annuzzi G; Rivellese A; Després JP; Borén J
J Intern Med; 2017 Aug; 282(2):187-201. PubMed ID: 28548281
[TBL] [Abstract][Full Text] [Related]
40. ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.
Gordts PL; Nock R; Son NH; Ramms B; Lew I; Gonzales JC; Thacker BE; Basu D; Lee RG; Mullick AE; Graham MJ; Goldberg IJ; Crooke RM; Witztum JL; Esko JD
J Clin Invest; 2016 Aug; 126(8):2855-66. PubMed ID: 27400128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
